What's in a name? A lot if you ask us. Introducing: Precision AQ. It's a nod to our mission, empowering access to life-changing medicine for all, but also our approach. IQ + EQ = Precision Access Quotient (AQ). We've fused together the science 🧪 (IQ) and empathy ❤️ (EQ) of nine diverse organizations into one brand to offer greater access to the services, data, expertise, and scale needed to navigate the therapy-to-patient journey. Learn more about our new blueprint for access: https://lnkd.in/gvB9eCJh
Precision AQ
Business Consulting and Services
Empowering access to life-changing medicines for all.
About us
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life changing medicines. Our global offerings include: • Commercial Consulting • HEOR • Market Access Marketing • Medical Communications • Advertising, Branding, and PR • Investor Relations and External Communications • Data and Product solutions Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
- Website
-
www.precisionaq.com
External link for Precision AQ
- Industry
- Business Consulting and Services
- Company size
- 1,001-5,000 employees
- Type
- Privately Held
- Specialties
- Market access, HEOR, Medical communications, Payer marketing, Pharma advertising, Advertising & PR, Investor Relations & External Communications, Omnichannel Solutions, Payer, Provider, Patient Data Solutions, Pharma commercialization research and strategy, Patient insights, and Learning & development
Employees at Precision AQ
Updates
-
The Centers for Medicare & Medicaid Services (CMS) has unveiled the States Advancing All-Payer Health Equity Approaches and Development (AHEAD) voluntary model meant to explore a state’s ability to improve to the overall health care management of its population. Maureen Hennessey, PhD, CPCC, CPHQ, SVP and Director of Value Transformation, dives into the exciting potential and unforeseen challenges of this model in an insightful discussion with First Report Managed Care. Curious about the AHEAD model and how this could reshape healthcare in your state? Get the insights: https://lnkd.in/eJBJwUNr
-
How can we transform patient partnership into a powerful catalyst for change? Our 2024 Good Patient Partnership Guide offers inspiration and guidance. Gain insights from one of our passionate contributors, Debra Montague, Founder and Chair of ALK Positive Lung Cancer UK, and see how partnering with patient groups can unlock access to transformative treatments: https://hubs.ly/Q02GKVd60
-
Commercial drug development requires special expertise – and we believe ER physicians deserve a spot at the table. Ross Maclean, EVP, Head of Medical Affairs and Linda Goldenberg, DO, share how their unique skillset and real world practice can provide greater access to life-changing medicine for all in Med Ad News: https://hubs.ly/Q02G9wT40 #pharmaindustry #drugdevelopment
-
We are thrilled to be nominated for four PM Society Digital Awards 🎉 Our nominations in Brand Promotion, Customer Experience Excellence, and Film, Animation, and Video are a testament to the dedication and collaboration of our teams and partners. It is our strong combination of passion, creativity and expertise that enables us to do great work. This recognition belongs to all involved! Looking forward to the awards ceremony in September and wishing all nominees the best of luck! #PMSocietyDigitalAwards #pharmamarketing
-
At the heart of healthcare lies a simple truth: patients and their well-being. To achieve true patient centricity, we need to set a higher standard. The 2024 Good Patient Partnership Guide is filled with practical tips and inspiring approaches to keep patients at the core of everything we do. Download the guide: https://hubs.ly/Q02FNMDf0 #patientcentricity #healthcare #patientadvocacy #patientinformation #patientvoice #patientpartners #patientexperience #pharmaceuticalindustry
-
In case you missed it: Doug Fulling, President of Precision AQ, sat down with MM+M to discuss how we're dismantling barriers to empower patient access in healthcare. From launching 57% of the FDA-approved drugs in 2023 to navigating the complexities along the access continuum, our team blends science with empathy to ensure life-changing therapies reach those in need. Our unique approach is reshaping the access landscape, focusing on payers, providers, and patients alike. 🎧 Put on your headphones & listen to the insightful discussion: https://hubs.ly/Q02FyJbN0 #MMMAgency100 #healthcaremarketing #pharmamarketing
-
Even as a therapy enters the “late lifecycle,” medical affairs teams can’t slow down. Continuing to empower access to medicine years after launch can look like: ⚫ Continued evidence generation ⚫ Demonstrating the value against generic competition ⚫ Exploring broader use applications Ross Maclean, Head of Medical Affairs, and Uchenna Iloeje, MD share why and how med affairs teams can drive “safe and appropriate use” activities forward in a feature for Healthcare Business Today: https://lnkd.in/ei5Dhmgn #pharmaindustry #marketaccess #biopharma
-
It’s been a great month for Pride at Precision. We asked colleagues to snap selfies showing their pride, and for every picture submitted we made a donation to the The Trevor Project, a leading organization dedicated to ending suicide among LGBTQ+ youth, and to IGLA Europe, which fights for LGBTI equality and human rights across Europe and Central Asia. It’s another way we highlight support for our LGBTQIA+ friends, colleagues, and family members around the world. #Pride #PrideMonth #pride2024 #TrevorProject #IGLAEurope
-
Pharma manufacturers are stepping up to help patients afford their medications through patient assistance programs (PAPs). But how can companies ensure these programs truly benefit patients? Enabling access to life-changing medicine requires effective PAPs. Learn to tailor your PAPs, measure success, and navigate market factors with insights from our team - Lauren Westberg, EVP, Managing Director, Courtney L. Ottoson, SVP, Director of Client Services, and Andrew Cournoyer, SVP, Director of Access Experience Team – in MMIT (Managed Markets Insight & Technology): https://lnkd.in/ePb8uuWa #PAPs #patientexperience #patientaccess #healthequity